Cyclo Therapeutics, Inc. Financial Ratios — CYTH Stock

Profitability (USD)

	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
As of date	12/31/2009	12/31/2010	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	-15.29	-2.33	-4.14	2.74	7.58	-14.68	-50.9	-127.81	-193.73	-169.98	-214.26	-97.72	-84.77	-130.19	-229.72
Return on Capital (%)	- -	- -	- -	-8.26	-18.58	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	5.44	11.94	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	82.24	85.71	73.47	86.63	74.84	82.61	86.91	86.8	89.26	89.62	92.5	92.65	90.16	89.9	92.16
EBITDA Margin (%)	-28.91	1.13	-4.02	30.34	34.14	-26.15	-220.57	-215.26	-309.54	-419.64	-733.23	-990.44	-898.71	-1,133.35	-1,860.9
Operating Margin (%)	-32.21	-1.48	-7.2	16.69	25.4	-35.87	-238.35	-222.38	-310.29	-420.64	-733.8	-991.85	-899.77	-1,134.76	-1,862.69
Incremental Operating Margin (%)	- -	- -	- -	1,898.95	39.44	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	-30.96	-1.56	-9.47	9.49	16.83	-37.81	-255.81	-281.04	-309.68	-420.68	-747.87	-989.8	-900.94	-1,123.08	-1,863.36
Profit Margin (%)	-30.96	-4.68	-9.47	7.1	12.1	-37.81	-268.44	-281.04	-309.68	-420.68	-747.87	-989.8	-900.94	-1,123.08	-1,863.36
Net Income to Common Margin (%)	-30.96	-4.68	-9.47	7.1	12.1	-37.81	-268.44	-281.04	-309.68	-420.68	-747.87	-989.8	-900.94	-1,123.08	-1,863.36
Effective Tax Rate (%)	- -	- -	- -	25.2	28.08	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API ChatGPT

	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
As of date	12/31/2009	12/31/2010	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023

Total Debt	- -	- -	1	1	1	1	1	- -	- -	- -	- -	- -	- -	- -	1
ST Debt	- -	- -	- -	- -	- -	1	1	- -	- -	- -	- -	- -	- -	- -	1
LT Debt	- -	- -	1	1	1	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Debt/EBITDA	- -	48.38	-20.16	3.11	1.47	-1.94	-0.35	- -	- -	- -	-0.01	-0.02	-0.01	- -	-0.05
Net Debt/EBITDA	1.88	36.61	-17.1	3.04	1.01	3.87	0.53	0.3	0.33	0.52	0.38	1.42	1.16	0.1	0.46
Total Debt/EBIT	- -	-36.99	-11.27	5.66	1.98	-1.41	-0.33	- -	- -	- -	-0.01	-0.02	-0.01	- -	-0.05
Net Debt/EBIT	1.69	-28	-9.56	5.52	1.36	2.82	0.49	0.29	0.33	0.52	0.38	1.42	1.15	0.1	0.46
EBITDA to Interest Expense	- -	2.11	-1.61	5.13	10.73	-12.17	-67	-113.1	- -	- -	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	- -	-102.23	-23.07	2.44	7.82	-17.34	-80.4	-113.43	- -	- -	- -	- -	- -	- -	- -
EBIT to Interest Expense	- -	-2.76	-2.88	2.82	7.98	-16.7	-72.4	-116.85	- -	- -	- -	- -	- -	- -	- -
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	-175.41	-119.56	-86.27	-89.1	-76.29	-51.45	-111.16	-508.04	-637.99	-602.45	-610.72	-240.07	-247.67	-1,513.53	-632.98
Long-Term Debt/Equity (%)	- -	30.4	50.08	48.48	44.31	- -	- -	- -	- -	- -	3.86	0.6	0.12	- -	0.47
Long-Term Debt/Capital (%)	- -	-22.79	-45.43	-55.74	-62.33	- -	- -	- -	- -	- -	-0.14	-0.19	-0.04	- -	-0.03
Long-Term Debt/Total Assets (%)	- -	22.07	25.57	28.67	28.52	- -	- -	- -	- -	- -	0.88	0.44	0.09	- -	0.17
Total Debt/Equity (%)	- -	31.3	58.74	63.67	47.45	18.18	19.69	- -	- -	- -	5.61	1.86	1.09	- -	21.72
Total Debt/Capital (%)	- -	-23.47	-53.29	-73.21	-66.74	-41.28	-16.27	- -	- -	- -	-0.21	-0.57	-0.35	- -	-1.25
Total Debt/Total Assets (%)	- -	22.72	29.99	37.66	30.54	15.03	15.56	- -	- -	- -	1.28	1.37	0.88	- -	7.8
Net Debt to Equity	-28.2	23.68	49.82	62.2	32.49	-36.28	-29.49	-62.92	-110.94	-223.41	-297.41	-121.38	-105.04	-210.12	-194.38
Net Debt/Capital (%)	12.98	-16.8	-41.81	-70.32	-37.76	36.83	17.33	9.19	8.71	11.2	9.99	27.16	25.41	2.36	10.04
EBITDA	- -	- -	- -	- -	1	- -	-2	-3	-4	-4	-7	-9	-14	-16	-20
EBITDA-CapEx	- -	- -	-1	- -	- -	-1	-3	-3	-4	-4	-7	-9	-14	-16	-20
Operating Income (Loss)	- -	- -	- -	- -	- -	-1	-2	-3	-4	-4	-7	-9	-14	-16	-20

Liquidity (USD)

API ChatGPT

	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
As of date	12/31/2009	12/31/2010	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023

Cash Ratio	12.24	1.04	0.19	0.07	1.35	2.6	1.85	2.8	1.35	1.15	0.89	3.5	4.34	0.44	1.09
Current Ratio	20.4	3.57	0.48	0.95	3.11	3.33	2.54	4.77	2.01	1.44	1.26	3.83	5.07	1.19	1.45
Quick Ratio	13.7	1.81	0.27	0.28	1.85	2.69	1.91	3.17	1.45	1.21	0.94	3.53	4.48	0.46	1.11
CFO/Avg Current Liab	2.17	3.22	0.49	0.12	2.15	-1.13	-2.08	-4.41	-4.76	-2.22	-2.6	-2.51	-4	-4.13	-2.71
Common Equity/Total Assets	-175.41	-119.56	-86.27	-89.1	-76.29	-51.45	-111.16	-508.04	-637.99	-602.45	-610.72	-240.07	-247.67	-1,513.53	-632.98
Long-Term Debt/Equity (%)	- -	30.4	50.08	48.48	44.31	- -	- -	- -	- -	- -	3.86	0.6	0.12	- -	0.47
Long-Term Debt/Capital (%)	- -	-22.79	-45.43	-55.74	-62.33	- -	- -	- -	- -	- -	-0.14	-0.19	-0.04	- -	-0.03
Long-Term Debt/Total Assets (%)	- -	22.07	25.57	28.67	28.52	- -	- -	- -	- -	- -	0.88	0.44	0.09	- -	0.17
Total Debt/Equity (%)	- -	31.3	58.74	63.67	47.45	18.18	19.69	- -	- -	- -	5.61	1.86	1.09	- -	21.72
Total Debt/Capital (%)	- -	-23.47	-53.29	-73.21	-66.74	-41.28	-16.27	- -	- -	- -	-0.21	-0.57	-0.35	- -	-1.25
Total Debt/Total Assets (%)	- -	22.72	29.99	37.66	30.54	15.03	15.56	- -	- -	- -	1.28	1.37	0.88	- -	7.8
CFO/Total Liabilities	115.43	39.67	13.6	5.47	55.97	-68.97	-199.91	-861.48	-324.75	-165.6	-207.4	-228.62	-389.85	-434.23	-190.62
CFO/CapEx	2.49	0.47	0.34	0.35	3.55	-3.63	-4.75	-315.84	-446.69	-1,077.54	-4,976.95	-160.75	-666.9	-1,001.87	-6,688.03
Altman's Z-Score	20.1	0.79	0.86	2.04	2.24	20.92	16.09	36.33	2.18	7.83	-6.19	-3.39	-1.14	-30.83	-11.59

Working Capital (USD)

API ChatGPT

	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
As of date	12/31/2009	12/31/2010	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023

Accounts Receivable Turnover	18.29	13.44	16.47	18.72	20.58	17.39	13.91	20.69	16.89	14.78	9.01	8.43	5.62	5.02	12.14
Days Sales Outstanding	19.96	27.15	22.17	19.5	17.73	20.99	26.23	17.64	21.6	24.7	40.49	43.32	64.92	72.71	30.07
Inventory Turnover	0.56	0.64	1.73	0.8	1.91	0.67	0.21	0.36	0.27	0.24	0.23	0.28	0.67	0.58	0.33
Days Inventory Outstanding	650.82	573.99	211.58	453.61	191.13	546.33	1,738.6	1,018.65	1,329.94	1,542.62	1,593.48	1,320.8	544.12	633.07	1,100.71
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	1.24	0.29	0.17	0.04	-0.1	- -	- -	0.15	0.02
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	294.83	1,278.48	2,197.98	10,399.64	-3,570.57	- -	- -	2,456.19	15,363.09
Cash Conversion Cycle	670.78	601.15	233.75	473.11	208.86	567.32	1,470	-242.18	-846.44	-8,832.32	5,204.55	1,364.12	609.04	-1,750.41	-14,232.31
Inventory to Cash Days	-630.87	-546.84	-189.42	-434.12	-173.39	-525.35	-1,712.36	-1,001.01	-1,308.33	-1,517.91	-1,552.99	-1,277.48	-479.19	-560.36	-1,070.64
Inventories	- -	- -	- -	- -	- -	1	1	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	1	1	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API ChatGPT

	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
As of date	12/31/2009	12/31/2010	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023

Market Capitalization	3	2	4	5	3	32	31	27	25	65	41	7	24	12	26
- Cash & Cash Equivalents	- -	- -	- -	- -	- -	2	2	1	1	2	3	13	17	2	9
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	1	1	1	1	1	- -	- -	- -	- -	- -	- -	- -	1
Enterprise Value	3	2	5	6	4	31	30	26	24	63	39	-6	7	10	18
Total Capital	-2	-2	-2	-1	-1	-2	-5	-9	-13	-18	-25	-34	-48	-64	-83
Total Debt/Capital (%)	- -	-23.47	-53.29	-73.21	-66.74	-41.28	-16.27	- -	- -	- -	-0.21	-0.57	-0.35	- -	-1.25
Total Debt / EV	- -	0.22	0.16	0.17	0.22	0.03	0.02	- -	- -	- -	- -	-0.03	0.02	- -	0.06
EV/Sales	4.99	2.51	4.94	5.49	2.32	19.63	31.36	17.49	19.34	62.47	38.32	- -	4.62	7.59	16.49
EV/EBITDA	- -	222.37	- -	18.08	6.79	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	32.87	9.13	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	28.77	9.06	24.1	54.73	6.6	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	20.53	3	6.66	21.16	5.22	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	3	2	4	5	3	32	31	27	25	65	41	7	24	12	26
Diluted Enterprise Value	3	2	5	6	4	31	30	26	24	63	39	-6	7	10	18
EV per Share	10.82	5.99	13.94	15.63	10.57	60.86	53.03	41.48	33.24	77.29	31.75	- -	1.15	1.24	1.09
TTM Sales	1	1	1	1	2	2	1	2	1	1	1	1	2	1	1
TTM EBITDA	- -	- -	- -	- -	1	- -	-2	-3	-4	-4	-7	-9	-14	-16	-20
TTM Operating Income	- -	- -	- -	- -	- -	-1	-2	-3	-4	-4	-7	-9	-14	-16	-20
TTM Cash Flow to Firm	- -	- -	- -	- -	1	-1	-2	-3	-3	-3	-7	-9	-15	-15	-16
TTM Free Cash Flow to Firm	- -	1	1	- -	1	- -	-2	-3	-3	-3	-7	-8	-15	-15	-16

Multiples (USD)

API ChatGPT

	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
As of date	12/31/2009	12/31/2010	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023

Price/Free Cash Flow	22.77	2.56	5.93	21.22	4.69	-70.74	-19.69	-9.26	-8.25	-20.53	-6.27	-0.82	-1.59	-0.79	-1.6
EV/EBIT	- -	- -	- -	32.87	9.13	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	3	2	5	6	4	31	30	26	24	63	39	-6	7	10	18
Low Price	1	3	3	7	6	7	39	25	25	25	16	3	3.43	0.91	0.67
EV/Sales	4.99	2.51	4.94	5.49	2.32	19.63	31.36	17.49	19.34	62.47	38.32	- -	4.62	7.59	16.49
EV/EBITDA	- -	222.37	- -	18.08	6.79	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	64.26	16.32	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	-10.1	-83.02	-39.71	81.84	19.07	-49.51	-12.57	-6.24	-8.19	-9.35	-7.17	-2.68	-3.36	-1.32	-1.12
Price/Earnings High	-29.77	-215.59	-74.82	128.52	25.39	-89.54	-17.62	-9	-15.03	-22.67	-13.56	-6.26	-7.91	-2.8	-2.09
Price/Earnings Low	-1.49	-26.95	-11.22	34.6	10.88	-5.97	-8.59	-3.75	-4.7	-4.8	-2.58	-0.54	-1.53	-0.5	-0.55
Price/Book Value	-1.52	-0.73	-1.82	-2.04	-1.57	-11.9	-5.87	-2.87	-1.89	-3.72	-1.65	-0.2	-0.49	-0.19	-0.31
Price/Book Value Average	-0.86	-1.35	-1.61	-2.6	-1.84	-10.79	-6.08	-2.78	-2.36	-2.26	-2.15	-0.7	-0.99	-0.32	-0.27
Price/Book Value High	-2.53	-3.5	-3.04	-4.09	-2.45	-19.52	-8.53	-4	-4.32	-5.49	-4.07	-1.64	-2.34	-0.68	-0.5
Price/Book Value Low	-0.13	-0.44	-0.46	-1.1	-1.05	-1.3	-4.16	-1.67	-1.35	-1.16	-0.77	-0.14	-0.45	-0.12	-0.13
Price/Tangible Book Value	2.88	1.21	3.08	3.08	1.86	7.4	8.25	17.85	22.01	65.9	44.16	0.67	1.52	16.31	5.46
Price/Tangible Book Value Average	1.63	2.24	2.73	3.92	2.18	6.71	8.56	17.27	27.41	40.1	57.68	2.29	3.06	27.71	4.73
Price/Tangible Book Value High	4.8	5.81	5.14	6.16	2.9	12.14	12.01	24.91	50.3	97.2	109.1	5.35	7.21	58.82	8.82
Price/Tangible Book Value Low	0.24	0.73	0.77	1.66	1.24	0.81	5.85	10.38	15.72	20.59	20.78	0.46	1.39	10.45	2.3
Price/Sales	5.53	2.1	4.25	4.56	1.98	20.64	32.53	18.13	20.37	64.66	41.04	7.7	14.98	8.71	24.12
Price/Sales Average	3.13	3.88	3.76	5.81	2.31	18.72	33.74	17.53	25.37	39.35	53.6	26.52	30.27	14.79	20.9
Price/Sales High	9.22	10.08	7.09	9.13	3.07	33.86	47.31	25.29	46.56	95.38	101.38	61.96	71.3	31.41	38.99
Price/Sales Low	0.46	1.26	1.06	2.46	1.32	2.26	23.06	10.54	14.55	20.21	19.31	5.31	13.78	5.58	10.16
Price/Cash Flow	31.91	8.03	23.62	81.51	6.01	-51.25	-15.54	-9.23	-8.23	-20.51	-6.27	-0.81	-1.58	-0.79	-1.6
Price/Cash Flow Average	18.03	14.85	20.9	103.81	7.02	-46.49	-16.12	-8.93	-10.25	-12.48	-8.19	-2.81	-3.2	-1.35	-1.39
Price/Cash Flow High	53.18	38.55	39.37	163.02	9.35	-84.08	-22.6	-12.88	-18.82	-30.26	-15.5	-6.55	-7.54	-2.86	-2.59
Price/Cash Flow Low	2.66	4.82	5.91	43.89	4.01	-5.61	-11.02	-5.37	-5.88	-6.41	-2.95	-0.56	-1.46	-0.51	-0.68
Price/Free Cash Flow Average	12.87	4.73	5.25	27.03	5.48	-64.17	-20.42	-8.96	-10.28	-12.5	-8.2	-2.82	-3.2	-1.35	-1.39
Price/Free Cash Flow High	37.95	12.28	9.89	42.45	7.29	-116.06	-28.64	-12.92	-18.86	-30.29	-15.5	-6.6	-7.55	-2.86	-2.59
Price/Free Cash Flow Low	1.9	1.53	1.48	11.43	3.13	-7.74	-13.96	-5.38	-5.89	-6.42	-2.95	-0.57	-1.46	-0.51	-0.68
EV/Sales Average	2.58	4.3	4.45	6.73	2.65	17.71	32.58	16.9	24.34	37.16	50.89	12.51	19.9	13.67	13.27
EV/Sales High	8.67	10.5	7.78	10.05	3.42	32.85	46.15	24.65	45.53	93.19	98.67	47.95	60.93	30.29	31.36
EV/Sales Low	- -	1.67	1.75	3.38	1.66	1.25	21.9	9.9	13.52	18.02	16.6	- -	3.41	4.46	2.53
EV/EBITDA Average	-8.93	379.96	-110.63	22.2	7.77	-67.72	-14.77	-7.85	-7.86	-8.86	-6.94	-1.26	-2.21	-1.21	-0.71
EV/EBITDA High	-30	928.24	-193.32	33.12	10.01	-125.61	-20.92	-11.45	-14.71	-22.21	-13.46	-4.84	-6.78	-2.67	-1.69
EV/EBITDA Low	0.28	148.07	-43.53	11.14	4.87	-4.76	-9.93	-4.6	-4.37	-4.29	-2.26	0.88	-0.38	-0.39	-0.14
EV/EBIT Average	-8.02	-290.56	-61.84	40.35	10.44	-49.36	-13.67	-7.6	-7.84	-8.83	-6.94	-1.26	-2.21	-1.2	-0.71
EV/EBIT High	-26.93	-709.83	-108.07	60.22	13.45	-91.56	-19.36	-11.09	-14.67	-22.15	-13.45	-4.83	-6.77	-2.67	-1.68
EV/EBIT Low	0.26	-113.23	-24.33	20.25	6.54	-3.47	-9.19	-4.45	-4.36	-4.28	-2.26	0.88	-0.38	-0.39	-0.14
Last Price	12	5	12	13	9	64	55	43	35	80	34	4.35	3.73	1.42	1.59
High Price	20	24	20	26	14	105	80	60	80	118	84	35	17.75	5.12	2.57
Enterprise Value Average	2	3	5	7	4	28	31	25	30	38	51	11	32	19	14
Enterprise Value High	5	8	8	11	6	51	44	37	56	94	99	43	97	42	34
Enterprise Value Low	- -	1	2	4	3	2	21	15	17	18	17	-8	5	6	3

Shares Outstanding	- -	- -	- -	- -	- -	1	1	1	1	1	1	5	8	8	29
Diluted Weighted Avg Shares	- -	- -	- -	- -	- -	1	1	1	1	1	1	2	6	8	16
Basic Weighted Avg Shares	- -	- -	- -	- -	- -	1	1	1	1	1	1	2	6	8	16
Revenue per Share	2.17	2.38	2.82	2.85	4.56	3.1	1.69	2.37	1.72	1.24	0.83	0.56	0.25	0.16	0.07
EBITDA per Share	-0.63	0.03	-0.11	0.86	1.56	-0.81	-3.73	-5.11	-5.32	-5.19	-6.08	-5.59	-2.24	-1.85	-1.23
Operating Income per Share	-0.7	-0.04	-0.2	0.48	1.16	-1.11	-4.03	-5.28	-5.33	-5.2	-6.08	-5.6	-2.24	-1.85	-1.23
Basic EPS, GAAP	-0.67	-0.11	-0.27	0.2	0.55	-1.17	-4.54	-6.67	-5.32	-5.2	-6.2	-5.59	-2.24	-1.83	-1.23
Basic EPS from Cont Ops	-0.67	-0.11	-0.27	0.2	0.55	-1.17	-4.54	-6.67	-5.32	-5.2	-6.2	-5.59	-2.24	-1.83	-1.23
Diluted EPS, GAAP	-0.67	-0.11	-0.27	0.2	0.55	-1.17	-4.54	-6.67	-5.32	-5.2	-6.2	-5.59	-2.24	-1.83	-1.23
Diluted EPS from Cont Ops	-0.67	-0.11	-0.27	0.2	0.55	-1.17	-4.54	-6.67	-5.32	-5.2	-6.2	-5.59	-2.24	-1.83	-1.23
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	0.38	0.62	0.51	0.16	1.5	-1.25	-3.54	-4.66	-4.25	-3.9	-5.42	-5.34	-2.36	-1.79	-0.99
Free Cash Flow per Basic Share	0.23	-0.71	-1.01	-0.29	1.08	-1.59	-4.29	-4.67	-4.26	-3.9	-5.42	-5.37	-2.36	-1.79	-0.99
Cash & Equivalents per Share	1.18	0.32	0.35	0.06	0.72	4.71	3.28	1.52	1.76	2.71	2.29	8.03	2.61	0.18	0.57
Book Value per Share	-7.9	-6.85	-6.58	-6.36	-5.73	-5.38	-9.38	-14.98	-18.5	-21.5	-20.66	-21.3	-7.59	-7.56	-5.14
Tangible Book Value per Share	4.17	4.13	3.89	4.22	4.83	8.65	6.66	2.41	1.59	1.21	0.77	6.54	2.46	0.09	0.29

Cyclo Therapeutics, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)